Skip to main content
Clinical Trials/KCT0007244
KCT0007244
Not yet recruiting
未知

Comparison of the hemodynamic stability of remimazolam versus dexmedetomidine during ultrasound-guided radiofrequency ablation of hepatic tumor under monitored anesthesia care

Asan Medical Center0 sites90 target enrollmentTBD
ConditionsNeoplasms

Overview

Phase
未知
Intervention
Not specified
Conditions
Neoplasms
Sponsor
Asan Medical Center
Enrollment
90
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing ultrasound\-guided percutaneous liver radiofrequency ablation under monitored anesthesia care

Exclusion Criteria

  • 1\. Patients with a history of drug allergy to dexmedetomidine, benzodiazepine, or opioid analgesics
  • 2\. Patients with contraindications to dexmedetomidine, remimazolam, or remifentanil
  • 3\. Patients with body classification 3 or higher by the American Society of Anesthesiologists Physical Status
  • 4\. Patients with a body mass index of 35 or higher
  • 5\. Child\-Pugh class C cirrhosis
  • 6\. Patients undergoing dialysis for end\-stage renal disease
  • 7\. Patients scheduled for RFA under general anesthesia
  • 8\. Patients judged to be inappropriate by other researchers

Outcomes

Primary Outcomes

Not specified

Similar Trials